John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AYX
601
PUT
DELISTED
Alteryx Inc
AYX
| $9.72M | 0.03% |
79,800
-22,900
| -22% | -$2.89M |
|
602
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$137M
| $9.7M | 0.03% |
9,025
+3,781
| +72% | +$4.91M |
|
603
MillerKnoll
MLKN
$1.58B
| $9.68M | 0.03% |
286,363
-260,655
| -48% | -$9.07M |
|
604
Radian Group
RDN
$4.86B
| $9.68M | 0.03% |
477,805
+262,056
| +121% | +$4.9M |
|
|
QVCGA
605
DELISTED
QVC Group Inc Series A
QVCGA
| $9.66M | 0.03% |
17,612
-22,156
| -56% | -$9.97M |
|
|
DOYU
606
DouYu International Holdings
DOYU
$128M
| $9.63M | 0.03% |
87,103
+26,483
| +44% | +$3.59M |
|
607
Sotera Health
SHC
$5.47B
| $9.61M | 0.03% |
+350,232
| New | +$9.4M |
|
608
CALL
Royal Caribbean
RCL
$78.4B
| $9.58M | 0.03% |
128,300
+1,600
| +1% | +$112K |
|
|
WCC
609
WESCO International
WCC
$16.4B
| $9.57M | 0.03% |
121,878
-117,784
| -49% | -$6.98M |
|
610
iShares S&P 500 Growth ETF
IVW
$75.6B
| $9.53M | 0.03% |
149,300
+137,600
| +1,176% | +$8.34M |
|
|
FPRX
611
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $9.52M | 0.03% |
559,429
+106,104
| +23% | +$1.33M |
|
612
CALL
Domino's
DPZ
$11.5B
| $9.51M | 0.03% |
24,800
+19,800
| +396% | +$7.78M |
|
|
613
CALL
Meta Platforms (Facebook)
META
$1.42T
| $9.48M | 0.03% |
34,700
+6,900
| +25% | +$1.89M |
|
614
Manhattan Associates
MANH
$12.4B
| $9.47M | 0.03% |
90,006
+13,382
| +17% | +$1.32M |
|
|
VCRA
615
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $9.46M | 0.03% |
227,725
+50,338
| +28% | +$1.73M |
|
616
Ionis Pharmaceuticals
IONS
$10.3B
| $9.45M | 0.03% |
167,205
-784,931
| -82% | -$39.1M |
|
|
617
PUT
Chevron
CVX
$398B
| $9.43M | 0.03% |
111,700
+40,400
| +57% | +$3.27M |
|
618
Impinj
PI
$4.92B
| $9.4M | 0.03% |
224,437
+24,651
| +12% | +$859K |
|
|
CMA
619
DELISTED
Comerica
CMA
| $9.37M | 0.03% |
167,736
-10,234
| -6% | -$499K |
|
620
Kimco Realty
KIM
$16.2B
| $9.36M | 0.03% |
623,289
+194,525
| +45% | +$2.57M |
|
|
AAWW
621
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $9.35M | 0.03% |
171,387
+146,765
| +596% | +$8.62M |
|
622
Accenture
ACN
$114B
| $9.33M | 0.03% |
+35,732
| New | +$8.57M |
|
623
Park Hotels & Resorts
PK
$3.19B
| $9.33M | 0.03% |
544,162
-76,683
| -12% | -$1.06M |
|
624
Pegasystems
PEGA
$5.64B
| $9.32M | 0.03% |
+139,922
| New | +$8.93M |
|
625
Dow Inc
DOW
$22.7B
| $9.31M | 0.03% |
+167,801
| New | +$8.66M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.